115 related articles for article (PubMed ID: 32067389)
1. Proteomic Analysis Reveals that EPHX1 Contributes to 5-Fluorouracil Resistance in a Human Hepatocellular Carcinoma Cell Line.
Sun R; Dong C; Li R; Chu H; Liu J; Hao D; Zhang L; Zhao B; Wang L; Zhang Y
Proteomics Clin Appl; 2020 Jul; 14(4):e1900080. PubMed ID: 32067389
[TBL] [Abstract][Full Text] [Related]
2. Quantitative proteomic and phosphoproteomic studies reveal novel 5-fluorouracil resistant targets in hepatocellular carcinoma.
Liu Z; Wang Y; Yao Y; Fang Z; Miao QR; Ye M
J Proteomics; 2019 Sep; 208():103501. PubMed ID: 31454556
[TBL] [Abstract][Full Text] [Related]
3. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
Ke M; Dong J; Wang Y; Zhang J; Zhang M; Wu Z; Lv Y; Wu R
Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug‑resistant human hepatocellular carcinoma cells to 5‑FU.
Tang B; Hu Z; Li Y; Yuan S; Wang Z; Yu S; He S
Mol Med Rep; 2016 Jan; 13(1):59-66. PubMed ID: 26549838
[TBL] [Abstract][Full Text] [Related]
5. Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line.
Gu W; Fang FF; Li B; Cheng BB; Ling CQ
Asian Pac J Cancer Prev; 2012; 13(9):4807-14. PubMed ID: 23167424
[TBL] [Abstract][Full Text] [Related]
6. Proteomic-based analysis for identification of proteins involved in 5-fluorouracil resistance in hepatocellular carcinoma.
Tan Y; Qin S; Hou X; Qian X; Xia J; Li Y; Wang R; Chen C; Yang Q; Miele L; Wu Q; Wang Z
Curr Pharm Des; 2014; 20(1):81-7. PubMed ID: 23530500
[TBL] [Abstract][Full Text] [Related]
7. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
[TBL] [Abstract][Full Text] [Related]
8. Rab27B enhances drug resistance in hepatocellular carcinoma by promoting exosome-mediated drug efflux.
Li R; Dong C; Jiang K; Sun R; Zhou Y; Yin Z; Lv J; Zhang J; Wang Q; Wang L
Carcinogenesis; 2020 Nov; 41(11):1583-1591. PubMed ID: 32390047
[TBL] [Abstract][Full Text] [Related]
9. Proteomic investigation of 5-fluorouracil resistance in a human hepatocellular carcinoma cell line.
Tong SW; Yang YX; Hu HD; An X; Ye F; Hu P; Ren H; Li SL; Zhang DZ
J Cell Biochem; 2012 May; 113(5):1671-80. PubMed ID: 22189913
[TBL] [Abstract][Full Text] [Related]
10. Opsin3 sensitizes hepatocellular carcinoma cells to 5-fluorouracil treatment by regulating the apoptotic pathway.
Jiao J; Hong S; Zhang J; Ma L; Sun Y; Zhang D; Shen B; Zhu C
Cancer Lett; 2012 Jul; 320(1):96-103. PubMed ID: 22313545
[TBL] [Abstract][Full Text] [Related]
11. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.
Lu F; Hou YQ; Song Y; Yuan ZJ
Anat Rec (Hoboken); 2013 Jan; 296(1):56-63. PubMed ID: 23125179
[TBL] [Abstract][Full Text] [Related]
12. Comparative proteomic analysis of protein methylation provides insight into the resistance of hepatocellular carcinoma to 5-fluorouracil.
Liu Z; Wang Q; Mao J; Wang K; Fang Z; Miao QR; Ye M
J Proteomics; 2020 May; 219():103738. PubMed ID: 32198070
[TBL] [Abstract][Full Text] [Related]
13. Biological features, gene expression profile, and mechanisms of drug resistance of two- and three-dimensional hepatocellular carcinoma cell cultures.
Mei N; Zhao N; Tian T; Jiao M; Li C
Pharmacol Res Perspect; 2021 Feb; 9(1):e00715. PubMed ID: 33486902
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound.
Hu Z; Lv G; Li Y; Li E; Li H; Zhou Q; Yang B; Cao W
J Exp Clin Cancer Res; 2016 Apr; 35():71. PubMed ID: 27102814
[TBL] [Abstract][Full Text] [Related]
15. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
Gu W; Liu L; Fang FF; Huang F; Cheng BB; Li B
Oncol Rep; 2014 Jan; 31(1):216-22. PubMed ID: 24173654
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-Specific Protease 22/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma.
Wen X; Ling S; Wu W; Shan Q; Liu P; Wang C; Wei X; Ding W; Teng X; Xu X
Dig Dis Sci; 2020 Apr; 65(4):1064-1073. PubMed ID: 31587155
[TBL] [Abstract][Full Text] [Related]
17. Metformin reverses multidrug resistance in human hepatocellular carcinoma Bel‑7402/5‑fluorouracil cells.
Ling S; Tian Y; Zhang H; Jia K; Feng T; Sun D; Gao Z; Xu F; Hou Z; Li Y; Wang L
Mol Med Rep; 2014 Dec; 10(6):2891-7. PubMed ID: 25310259
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of histone acetylation reverses organic anion transporter 2 repression and enhances 5-fluorouracil sensitivity in hepatocellular carcinoma.
Wang Y; Zhu Q; Hu H; Zhu H; Yang B; He Q; Yu L; Zeng S
Biochem Pharmacol; 2021 Jun; 188():114546. PubMed ID: 33838133
[TBL] [Abstract][Full Text] [Related]
19. H1, a derivative of tetrandrine, enhances the efficacy of 5-FU in Bel7402/5-FU cells via suppressing STAT3/MCL-1 and inducing PUMA.
Li F; Wang J; Wu N; Zhang H; Li Z; Wei N
Biochem Biophys Res Commun; 2019 Nov; 520(1):93-98. PubMed ID: 31582208
[TBL] [Abstract][Full Text] [Related]
20. Nestin overexpression in hepatocellular carcinoma associates with epithelial-mesenchymal transition and chemoresistance.
Zhang Y; Zeng S; Ma J; Deng G; Qu Y; Guo C; Shen H
J Exp Clin Cancer Res; 2016 Jul; 35(1):111. PubMed ID: 27412382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]